LH Laboratory Corporation of America Holdings

Price (delayed)

$190.59

Market cap

$18.53B

P/E Ratio

58.28

Dividend/share

N/A

EPS

$3.27

Enterprise value

$25.32B

Sector: Healthcare
Industry: Diagnostics & Research
Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Highlights

The quick ratio has grown by 4.5% from the previous quarter
LH's revenue is up by 2.8% year-on-year
The price to earnings (P/E) is 190% higher than the 5-year quarterly average of 20.1 and 131% higher than the last 4 quarters average of 25.2
LH's net income has plunged by 64% YoY and by 61% from the previous quarter

Key stats

What are the main financial stats of LH
Market
Shares outstanding
97.2M
Market cap
$18.53B
Enterprise value
$25.32B
Valuations
Price to earnings (P/E)
58.28
Price to book (P/B)
2.64
Price to sales (P/S)
1.6
EV/EBIT
30.86
EV/EBITDA
15.87
EV/Sales
2.19
Earnings
Revenue
$11.59B
EBIT
$820.5M
EBITDA
$1.6B
Free cash flow
$1.07B
Per share
EPS
$3.27
Free cash flow per share
$11
Book value per share
$72.15
Revenue per share
$119.09
TBVPS
$61.71
Balance sheet
Total assets
$17.3B
Total liabilities
$10.26B
Debt
$7.12B
Equity
$7.02B
Working capital
$433.1M
Liquidity
Debt to equity
1.01
Current ratio
1.18
Quick ratio
0.93
Net debt/EBITDA
4.26
Margins
EBITDA margin
13.8%
Gross margin
27.5%
Net margin
2.8%
Operating margin
7.1%
Efficiency
Return on assets
1.8%
Return on equity
4.4%
Return on invested capital
7.9%
Return on capital employed
5.5%
Return on sales
7.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$11.59B
Gross profit
$3.19B
Operating income
$819.4M
Net income
$321M
Gross margin
27.5%
Net margin
2.8%
The net margin has dropped by 65% year-on-year and by 61% since the previous quarter
LH's net income has plunged by 64% YoY and by 61% from the previous quarter
The operating margin has contracted by 40% YoY and by 38% from the previous quarter
Laboratory Corp Of America Holdings's operating income has decreased by 39% YoY and by 38% QoQ

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
58.28
P/B
2.64
P/S
1.6
EV/EBIT
30.86
EV/EBITDA
15.87
EV/Sales
2.19
The price to earnings (P/E) is 190% higher than the 5-year quarterly average of 20.1 and 131% higher than the last 4 quarters average of 25.2
Laboratory Corp Of America Holdings's EPS has shrunk by 63% YoY and by 61% QoQ
The P/B is 26% higher than the last 4 quarters average of 2.1 and 15% higher than the 5-year quarterly average of 2.3
The company's equity fell by 7% QoQ
LH's price to sales (P/S) is 14% higher than its 5-year quarterly average of 1.4 and 14% higher than its last 4 quarters average of 1.4
LH's revenue is up by 2.8% year-on-year

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
LH's ROA has shrunk by 67% YoY and by 62% QoQ
LH's ROE has shrunk by 65% YoY and by 61% QoQ
The company's return on invested capital has shrunk by 53% YoY and by 40% QoQ
Laboratory Corp Of America Holdings's return on sales has decreased by 47% YoY and by 39% QoQ

Dividends

What is LH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LH.

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 69% greater than its total liabilities
Laboratory Corp Of America Holdings's current ratio has increased by 5% from the previous quarter and by 3.5% YoY
LH's debt to equity is up by 7% since the previous quarter and by 5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.